Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 294
Selected: 0
NCT IDTitle
NCT03609203Improving Self-Efficacy, Resolving Inflammaging Allo HSCT Survivors in Personal Training
NCT06693986Adenovirus (RGDCRAdCOX2F)
NCT00609739Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation
NCT07541573GTB-5550 in Advanced Solid Tumors
NCT00262951Chemoradiation in Locally Advanced Pancreatic Cancer
NCT06544811American Indian Smokefree Native RCT
NCT00652899Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer
NCT07070726UNTOLD Ovarian Cancer Unmet Needs Survey
NCT04228952Metabolism of NNK in Japanese Americans
NCT05643014Observational Study of Exposure to Environmental Toxicants Among Firefighters
NCT03383055CMV-MVA Triplex Vac.Enhance Adap. NK Cell Recon. After Auto HSCT in pt Lymphoid Malig
NCT02141451ADAM17 Inhibitor/ Rituximab After Auto HCT for DLBCL
NCT00432094Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors
NCT01685411Busulfan and Cyclophosphamide Followed By ALLO BMT
NCT04284254MT2018-18: Sleeping Beauty Transposon-Engineered Plasmablasts for Hurler Syndrome Post Allo HSCT
NCT03981705Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer
NCT06322992App-Assisted Day Reconstruction to Reduce Treatment Burden and Logistic Toxicity in Cancer Patients - Aim 3
NCT01885897IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT
NCT00871689Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML
NCT02988843Study of Brentuximab Vedotin And Bevacizumab In Refractory CD-30 Positive Germ Cell Tumors
NCT04928950Charcoal in Lung Cancer Patients Undergoing TEMLA
NCT01105650Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer
NCT06414278Evaluation of Early Identification of Cognitive Side Effects of Immunotherapy
NCT03314974Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
NCT06213298Effect of Kava on Anxiety and Stress in Cancer Survivors
NCT06872333Allo HSCT for High Risk Hemoglobinopathies
NCT00095160Safety Study of an Immune Response Modifier in Patients With Refractory Solid Organ Tumors
NCT00005993Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer
NCT01207076AHN-12 Biodistribution in Advanced Leukemia
NCT02500472Investigation of Kava Effects on NNK Metabolism
NCT00290654Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ
NCT05120570PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation
NCT01526603High Dose Chemotherapy and Autologous Transplant for Neuroblastoma
NCT00346125PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma
NCT00888316Iron Overload in Patients Undergoing Donor Stem Cell Transplant
NCT06594445HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML
NCT05809557EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity
NCT00376805Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast Cancer
NCT01677949Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia
NCT00618540Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis
NCT03125642Auto Stem Cell Transplant for Lymphoma Patients
NCT00000105Vaccination With Tetanus and KLH to Assess Immune Responses.
NCT03365661QUILT-3.034: Non-Myeloablative TCRa/b Deplete Haplo HSCT With Post ALT-803 for AML
NCT00006451Bone Marrow Transplantation in Treating Patients With Leukemia
NCT00769990Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases
NCT05447156QuitGuide for American Indians: Aims 2 & 3
NCT00167219Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)
NCT02525029Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD
NCT00303719Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy
NCT00365287Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer